7 completed, 4 recruiting, 3 terminated. 4 Phase 1, 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 2 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cutaneous Lupus: new trials by email Literature Review of Cutaneous Lupus trials Research Report on Cutaneous Lupus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases Sampling - Atopic Dermatitis, Psoriasis | Recruiting | Assistance Publique - Hôpitaux de Paris | 830 | 2025-10-20 | 2026-06-12 | |
| Determinants of Chronic Inflammatory Skin Disease Trajectories Topical and systemic drugs - Atopic Dermatitis, Psoriasis | Recruiting | University Hospital Schleswig-Holstein | 1000 | 2023-05-01 | 2026-08-28 | |
| Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus Questionnaires - Cutaneous Lupus | Completed | University Hospital, Toulouse | 202 | 2022-10-08 | 2026-05-12 | |
| Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus Tofacitinib - Cutaneous Lupus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 7 | 2022-09-30 | 2025-08-22 |
| Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone 532nm laser, 1064nm laser, Topical corticosteroid - Cutaneous Lupus | Not applicable | Terminated | David Weinstein | 3 | 2018-08-17 | 2021-07-21 |
| Maternal Autoimmune Disease Research Alliance (MADRA) Registry Autoimmune Diseases, Pregnancy Related | Recruiting | Duke University | 1000 | 2018-01-01 | 2026-01-08 | |
| Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus Tofacitinib - Cutaneous Lupus, Systemic Lupus Erythematosus | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2017-08-23 | 2026-03-03 |
| Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases Thalidomide, Hydroxychloroquine reduced, standard dose of HCQ - Systemic Lupus Erythematosus (SLE), Juvenile SLE | Phase 4 | Completed | University of Sao Paulo General Hospital | 93 | 2017-06-05 | 2021-12-16 |
| Cutaneous Lupus Medication Experience Study fluocinonide 0.05% cream - Cutaneous Lupus | Completed | Wake Forest University Health Sciences | 11 | 2014-12-01 | 2025-04-24 | |
| Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus AMG 557, AMG 557 Placebo - Cutaneous Lupus, Lupus | Phase 1 | Terminated | Amgen | 1 | 2011-10-01 | 2014-01-10 |
| Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus AMG811, AMG811 Placebo - Cutaneous Lupus, Discoid Lupus | Phase 1 | Terminated | Amgen | 16 | 2010-08-01 | 2014-09-16 |
| Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus Lenalidomide - Cutaneous Lupus | Phase 4 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 15 | 2010-01-01 | 2011-08-03 |
| Duke Autoimmunity in Pregnancy Registry Pregnancy, Systemic Lupus Erythematosus | Completed | Duke University | 513 | 2007-08-01 | 2019-10-23 | |
| Duke Lupus Registry Systemic Lupus Erythematosus, Cutaneous Lupus | Recruiting | Duke University | 1000 | 2007-07-01 | 2026-01-08 |
Lupus Erythematosus, Systemic (6) · Arthritis, Rheumatoid (2) · Dermatitis, Atopic (2) · Hidradenitis Suppurativa (2) · Lichen Planus (2) · Psoriasis (2) · Scleroderma, Diffuse (2) · Sjogren's Syndrome (2) · Alopecia Areata (1) · Autoimmune Diseases (1) · Dermatomyositis (1) · Lupus Erythematosus, Discoid (1) · Rosacea (1) · Skin Diseases, Vascular (1) · Vitiligo (1)
Immune System Diseases (8) · Skin and Connective Tissue Diseases (8) · Connective Tissue Diseases (7) · Autoimmune Diseases (5) · Skin Diseases (5) · Musculoskeletal Diseases (3) · Arthritis (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dermatitis (2) · Dry Eye Syndromes (2) · Eye Diseases (2) · Genetic Diseases, Inborn (2) · Hidradenitis (2)
tofacitinib (2) · AMG 557 (1) · Adrenal Cortex Hormones (1) · Fluocinonide (1) · Hydroxychloroquine (1) · Lasers (1) · Lenalidomide (1) · Surveys and Questionnaires (1) · Thalidomide (1)
Duke University (3) · Amgen (2) · Assistance Publique - Hôpitaux de Paris (1) · Children's Hospital Medical Center, Cincinnati (1) · David Weinstein (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Hospital Schleswig-Holstein (1) · University Hospital, Toulouse (1) · University of Sao Paulo General Hospital (1) · Wake Forest University Health Sciences (1)
United States (9) · France (2) · Australia (1) · Brazil (1) · Canada (1) · Germany (1) · Spain (1)
Megan E. B. Clowse, MD, MPH (2) · Eloisa Bonfa, MD, PhD (1) · Hermine Brunner, MD (1) · Joanne M Kahlenberg, M.D., Ph.D. (1) · Megan EB Clowse, MD, MPH (1) · Sascha Gerdes, MD (1) · William W Huang, MD, MPH, FAAD (1)
PMID 23217273, PMID 28118537, PMID 33486596
2009 (1)